Brief: BioArctic Says Sales Of Leqembi Totaled 13.3 Bln Yen In Q4 2024
07/02/2025 03:35
Feb 6 (Reuters) - BioArctic AB BIOAb.ST :
* BIOARCTIC AB: SALES OF LEQEMBI® TOTALED 13.3 BILLION YEN
IN Q4
2024
Source text: ID:nWkr4k7fPW
Further company coverage: BIOAb.ST
((reuters.briefs@thomsonreuters.com;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln